IL6 and metabolic dysfunction-associated steatotic liver disease: It also has a strong anti‐inflammatory effect, which is achieved by inhibiting inflammation‐related enzymes such as Cyclooxygenase‐2 (COX‐2), which ultimately reduces the production of NAFLD‐inducing inflammatory factors such as Tumor Necrosis Factor‐Alpha (TNF‐α) and Interleukin‐6 (IL‐6).